Volume 30, Issue 3 (September 2026)                   Physiol Pharmacol 2026, 30(3): 353-363 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rajabi S, Aminizadeh S, Kazeminia S, Najafipour H, Askaripour M, Bejeshk M A, et al . Endurance training and MitoQ attenuate renal injury in ovariectomized rats with unilateral ureteral obstruction. Physiol Pharmacol 2026; 30 (3) :353-363
URL: http://ppj.phypha.ir/article-1-2674-en.html
Abstract:   (401 Views)

Introduction: Oxidative stress and inflammation are recognized as key contributors to the unilateral ureteral obstruction (UUO). The present study aimed to evaluate the potential effect of endurance training (ET) and the mitochondria-targeted antioxidant MitoQ, administered separately or in combination, in ovariectomized (OVX) rats subjected to UUO-induced renal damage.
Methods: Fifty-six OVX female Wistar rats were randomly assigned to eight groups (n = 7/group): Sham, Sham+ET, Sham+MitoQ, Sham+ET+MitoQ, UUO, UUO+ET, UUO+MitoQ, and UUO+ET+MitoQ. ET was performed on a treadmill for four weeks, while MitoQ (5 mg/kg/day, IP) was administered throughout the intervention period. Histopathological alterations, oxidative stress markers, antioxidant status, and inflammatory cytokines were evaluated in obstructed kidneys.
Results: Histological analysis demonstrated significant tubular injury, fibrosis, glomerulosclerosis, and inflammation in UUO rats (P < 0.001). Moreover, UUO increased renal malondialdehyde (MDA), tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) levels, while significantly reducing total antioxidant capacity (TAC) and superoxide dismutase (SOD) activity (P < 0.001). ET or MitoQ treatment significantly attenuated these pathological alterations, whereas combined therapy exerted greater protective effects than either intervention alone.
Conclusion: ET and MitoQ supplementation effectively ameliorated UUO injury in OVX rats by suppressing oxidative stress and inflammation. Combined intervention produced superior reno-protective effects, compared with either intervention alone. These findings suggest that ET and MitoQ may represent a promising therapeutic approach within the experimental ovariectomized UUO model.

Full-Text [PDF 1554 kb]   (38 Downloads)    

References
1. Aminizadeh S, Habibi A, Masoumi-Ardakani Y, Shahouzehi B, Marefati H, Shakerian S. The role of estrogen-related receptor α (ERRα) in metabolic adaptations by endurance training in skeletal muscle of streptozotocin-induced diabetic rats. Sport Sciences for Health 2021; 17: 585-596. [DOI:10.1007/s11332-020-00714-7]
2. Askaripour M, Najafipour H, Saberi S, Jafari E, Rajabi S. Daidzein mitigates oxidative stress and inflammation in the injured kidney of ovariectomized rats: AT1 and Mas receptor functions. Iranian Journal of Kidney Diseases 2022a; 16: 32-43.
3. Askaripour M, Najafipour H, Saberi S, Yazdani S, Jafarinejad-Farsangi S, Rajabi S, et al. Isoflavone daidzein ameliorates renal dysfunction and fibrosis in a postmenopausal rat model: Intermediation of angiotensin AT1 and Mas receptors and microRNAs 33a and 27a. Iranian Journal of Basic Medical Sciences 2022b; 25: 1317-1325.
4. Castaneda C, Gordon P L, Parker R C, Uhlin K L, Roubenoff R, Levey A S. Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. American Journal of Kidney Diseases 2004; 43: 607-616. [DOI:10.1053/j.ajkd.2003.12.025]
5. Chacko B K, Srivastava A, Johnson M S, Benavides G A, Chang M J, Ye Y, et al. Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis. Hepatology 2011; 54: 153-163. [DOI:10.1002/hep.24377]
6. Cheema B S. Review article: Tackling the survival issue in end-stage renal disease: time to get physical on haemodialysis. Nephrology (Carlton) 2008; 13: 560-569. [DOI:10.1111/j.1440-1797.2008.01036.x]
7. Chevalier R L, Forbes M S, Thornhill B A. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney International 2009; 75: 1145-1152. [DOI:10.1038/ki.2009.86]
8. Dendooven A, Ishola D A, Jr., Nguyen T Q, Van der Giezen D M, Kok R J, Goldschmeding R, et al. Oxidative stress in obstructive nephropathy. International Journal of Experimental Pathology 2011; 92: 202-210. [DOI:10.1111/j.1365-2613.2010.00730.x]
9. Escribano-Lopez I, Diaz-Morales N, Rovira-Llopis S, de Marañon A M, Orden S, Alvarez A, et al. The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients. Redox Biology 2016; 10: 200-205. [DOI:10.1016/j.redox.2016.10.017]
10. Graham D, Huynh N N, Hamilton C A, Beattie E, Smith R A, Cochemé H M, et al. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 2009; 54: 322-328. [DOI:10.1161/HYPERTENSIONAHA.109.130351]
11. Gu Q, Zhao L, Ma Y P, Liu J D. Contribution of mitochondrial function to exercise-induced attenuation of renal dysfunction in spontaneously hypertensive rats. Molecular and Cellular Biochemistry 2015; 406: 217-225. [DOI:10.1007/s11010-015-2439-6]
12. Hammad F T, Lubbad L, Al-Salam S, Yasin J, Meeran M F N, Ojha S, et al. The effect of hypertension on the recovery of renal dysfunction following reversal of unilateral ureteral obstruction in the rat. International Journal of Molecular Sciences 2023; 24. [DOI:10.3390/ijms24087365]
13. Hassan N M E, Said E, Shehatou G S G. Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3/NF-κB signaling, oxidative stress and inflammation. Life Sciences 2021; 272: 119241. [DOI:10.1016/j.lfs.2021.119241]
14. Huang T, Shen J, Bao B, Hu W, Sun Y, Zhu T, et al. Mitochondrial-targeting antioxidant MitoQ modulates angiogenesis and promotes functional recovery after spinal cord injury. Brain Research 2022; 1786: 147902. [DOI:10.1016/j.brainres.2022.147902]
15. Jeong J H, Koo J H, Yook J S, Cho J Y, Kang E B. Neuroprotective benefits of exercise and mitoQ on memory function, mitochondrial dynamics, oxidative stress, and neuroinflammation in D-galactose-induced aging rats. Brain Sciences 2021; 11. [DOI:10.3390/brainsci11020164]
16. Kelso G F, Porteous C M, Coulter C V, Hughes G, Porteous W K, Ledgerwood E C, et al. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. Journal of Biological Chemistry 2001; 276: 4588-4596. [DOI:10.1074/jbc.M009093200]
17. Klahr S, Pukerson M L. The pathophysiology of obstructive nephropathy: the role of vasoactive compounds in the hemodynamic and structural abnormalities of the obstructed kidney. American Journal of Kidney Diseases 1994; 23: 219-223. [DOI:10.1016/S0272-6386(12)80975-9]
18. Li Q, Li K, Chen Z, Zhou B. Anti-renal fibrosis and anti-inflammation effect of urolithin B, ellagitannin-gut microbial-derived metabolites in unilateral ureteral obstruction rats. Journal of Functional Foods 2020; 65: 103748. [DOI:10.1016/j.jff.2019.103748]
19. Lønbro S, Wiggins J M, Wittenborn T, Elming P B, Rice L, Pampo C, et al. Reliability of blood lactate as a measure of exercise intensity in different strains of mice during forced treadmill running. PLoS One 2019; 14: e0215584. [DOI:10.1371/journal.pone.0215584]
20. Martínez-Klimova E, Aparicio-Trejo O E, Gómez-Sierra T, Jiménez-Uribe A P, Bellido B, Pedraza-Chaverri J. Mitochondrial dysfunction and endoplasmic reticulum stress in the promotion of fibrosis in obstructive nephropathy induced by unilateral ureteral obstruction. Biofactors 2020; 46: 716-733. [DOI:10.1002/biof.1673]
21. Martínez-Klimova E, Aparicio-Trejo O E, Tapia E, Pedraza-Chaverri J. Unilateral Ureteral Obstruction as a Model to Investigate Fibrosis-Attenuating Treatments. Biomolecules 2019; 9. [DOI:10.3390/biom9040141]
22. Masoumi-Ardakani Y, Najafipour H, Nasri H R, Aminizadeh S, Jafari S, Moflehi D. Effect of combined endurance training and MitoQ on cardiac function and serum level of antioxidants, NO, miR-126, and miR-27a in hypertensive individuals. BioMed Research International 2022a; 2022: 8720661. [DOI:10.1155/2022/8720661]
23. Masoumi-Ardakani Y, Najafipour H, Nasri H R, Aminizadeh S, Jafari S, Safi Z. Moderate endurance training and MitoQ improve cardiovascular function, oxidative stress, and inflammation in hypertensive individuals: the role of miR-21 and miR-222: a randomized, double-blind, clinical trial. Cell Journal 2022b; 24: 577-585.
24. Melo L, Bilici M, Hagar A, Klaunig J E. The effect of endurance training on non-alcoholic fatty liver disease in mice. Physiological Reports 2021; 9: e14926. [DOI:10.14814/phy2.14926]
25. Pei G, Tang Y, Tan L, Tan J, Ge L, Qin W. Aerobic exercise in adults with chronic kidney disease (CKD): a meta-analysis. International Urology and Nephrology 2019; 51: 1787-1795. [DOI:10.1007/s11255-019-02234-x]
26. Racusen L C, Solez K, Colvin R B, Bonsib S M, Castro M C, Cavallo T, et al. The Banff 97 working classification of renal allograft pathology. Kidney International 1999; 55: 713-723. [DOI:10.1046/j.1523-1755.1999.00299.x]
27. Rao B, Soufir J C, Martin M, David G. Lipid peroxidation in human spermatozoa as related to midpiece abnormalities and motility. Gamete Research 1989; 24: 127-134. [DOI:10.1002/mrd.1120240202]
28. Roshan V D, Assali M, Moghaddam A H, Hosseinzadeh M, Myers J. Exercise training and antioxidants: effects on rat heart tissue exposed to lead acetate. International Journal of Toxicology 2011; 30: 190-196. [DOI:10.1177/1091581810392809]
29. Rostamzadeh F, Najafipour H, Aminizadeh S, Jafari E. Therapeutic effects of the combination of moderate-intensity endurance training and MitoQ supplementation in rats with isoproterenol-induced myocardial injury: The role of mitochondrial fusion, fission, and mitophagy. Biomed Pharmacother 2024; 170: 116020. [DOI:10.1016/j.biopha.2023.116020]
30. Smith R A, Murphy M P. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Annals of the New York Academy of Sciences 2010; 1201: 96-103. [DOI:10.1111/j.1749-6632.2010.05627.x]
31. So B, Park J, Jang J, Lim W, Imdad S, Kang C. Effect of aerobic exercise on oxidative stress and inflammatory response during particulate matter exposure in mouse lungs. Front Physiol 2021; 12: 773539. [DOI:10.3389/fphys.2021.773539]
32. Srivastava A, Tomar B, Sharma D, Rath S K. Mitochondrial dysfunction and oxidative stress: Role in chronic kidney disease. Life Sciences 2023; 319: 121432. [DOI:10.1016/j.lfs.2023.121432]
33. Stump C S. Physical activity in the prevention of chronic kidney disease. Cardiorenal Medicine 2011; 1: 164-173. [DOI:10.1159/000329929]
34. Xiao L, Xu X, Zhang F, Wang M, Xu Y, Tang D, et al. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1. Redox Biology 2017; 11: 297-311. [DOI:10.1016/j.redox.2016.12.022]
35. Zadeh H J, Roholamini Z, Aminizadeh S, Deh-Ahmadi M A. Endurance training and MitoQ supplementation improve spatial memory, VEGF expression, and neurogenic factors in hippocampal tissue of rats. Journal of Clinical and Translational Research 2023; 9: 1-7. [DOI:10.18053/jctres.09.202301.001]
36. Zoladz J A, Koziel A, Woyda-Ploszczyca A, Celichowski J, Jarmuszkiewicz W. Endurance training increases the efficiency of rat skeletal muscle mitochondria. Pflugers Archiv 2016; 468: 1709-1724. [DOI:10.1007/s00424-016-1867-9]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.